Saturday August 24, 2019 08:00

Food and Healthcare Press Releases

Biotech Conagen Acquires Production Platform of Therapeutic Proteins Heathcare—22 Aug 19

Conagen, a vertically integrated synthetic biology company located in Boston's biotech corridor, announced today that it has acquired a fermentation-based technology for the production of therapeutically useful glycoproteins. The acquisition includes

Pneuma Respiratory, Inc. Announces New Chairman of the Board Heathcare—22 Aug 19

Pneuma Respiratory, Inc. announced that Board member Jay Morgan has assumed the position of Chairman of the Board. Pneuma's previous Chairman, Walt Robb, will remain a member of the Board of Directors. Jay Morgan served as VP Global Innovation and

Global market of dietary supplement is welcoming a rising star GLYMATE Heathcare—19 Aug 19

Glymate(TM), a newly founded nutraceutical company in Southern California. Its proprietary sugar balance dietary supplement was officially announced in the United States in June 2019, marking the official launch of the global marketing of this product,

Xinhua Silk Road: Tasly remains China#s 2019 National Tech Innovation Demonstration Heathcare—16 Aug 19

Tasly Holding Group, one of China's leading pharmaceuticals companies, has recently passed through the country's review of National Technology Innovation Demonstration Enterprise in 2019, thanks to its continuous innovations made in the recent

SweeGen#s non-GMO Reb M Stevia Leaf Sweetener Approved in Singapore Heathcare—09 Aug 19

SweeGen, Inc., a nature-based sweetener company, announced the Singapore Food Agency has added SweeGen's Reb M Stevia Leaf Sweetener to the list of permitted food additives. SweeGen's Reb M is a non-caloric stevia sweetener that provides sweetness with

EVERSANA(TM) opens offices in Singapore Mumbai as Asia Pacific commercial business rapidly Heathcare—07 Aug 19

EVERSANA(TM), the leading independent provider of global commercial services to the life science industry, today announced the rapid expansion of its Asia Pacific business with the addition of two new offices in Singapore and Mumbai. The announcement

@BactLAB(TM), Bacterial Colony-counting Service, Now Available Globally Heathcare—05 Aug 19

Nissui Pharmaceutical Co., Ltd., based in Tokyo, is pleased to announce that @BactLAB(TM), an application that uses Amazon Web Service (AWS) Cloud and artificial intelligence (AI) technologies to enable quick and easy counting of bacterial colonies, is

INC Research Grant is Now Open Heathcare—01 Aug 19

The International Nut and Dried Fruit Council (INC) has just launched its Annual Call for Research Projects (EUR300,000) to fund clinical, epidemiological, basic and/or strategic research that may contribute to enhancing the understanding of the health

ERBA Mannheim to Unveil NEXUS Next Generation Automation at AACC 2019 Heathcare—01 Aug 19

- New affordable, modular, mid-scale clinical chemistry, immunoassay and hematology range with sample selection and transport systems, making powerful automation accessible to growing labs - Hematology system uses unique combination of ultra-high

Brunei Royalty Launches Shine X, A Boutique Fitness Studio Designed By The Texas-Based Firm, Indoor Heathcare—31 Jul 19

Her Royal Highness Princess 'Azemah Ni'matul Bolkiah enlisted the award-winning talents of Indoor Cycle Design to expand the Shine fitness brand in southeast Asia. In pursuit of expanding premium boutique fitness in Brunei, Her Royal Highness Princess

Internationally Renowned Radiation Oncologist, Prof. Dr. Dattatreyudu Nori Appointed as Heathcare—30 Jul 19

Apollo Hospitals have appointed world renowned Radiation Oncologist, Prof. Dr. Dattatreyudu Nori, as International Director – Apollo Cancer Centres, Apollo Hospitals Group. Beginning this month, Dr. Nori will be available for consultations 10 times

Verb Surgical Announces Kurt Azarbarzin as President and CEO Heathcare—25 Jul 19

Verb Surgical Inc. today announced that Kurt Azarbarzin has joined the company as President and Chief Executive Officer, effective immediately. "I am incredibly honored and excited to have the opportunity to lead Verb," said Azarbarzin. "The company has

Doctors Talk: Preventive Healthcare Can Lead to a Healthier, Happier Heathcare—24 Jul 19

Today, many countries are burdened with the rising costs of health care. People are paying very high prices for medical services including hospitalization, tests, doctors' visits and prescription drugs. Among the major causes of rising health care costs

Novo Nordisk (Thailand) is hosting a press conference for the topic of Rethink Heathcare—19 Jul 19

Mr. John Dawber, Vice President and General Manager at Novo Nordisk (Thailand) is hosting a press conference for the topic of "Rethink Obesity". The event will be chaired by His Excellency Mr. Uffe Wolffhechel, Ambassador of Denmark to Thailand, and will

Brain Health Supplements Market Expecting an Outstanding Growth Till Heathcare—17 Jul 19

The global brain health supplements market size is expected to reach USD 10.7 billion by 2025, according to a new report by Grand View Research, Inc., expanding at a CAGR of 8.2% over the forecast period. Growing health concerns over depression, anxiety,

Menarini Silicon Biosystems Launches VRNxT Volume Reduction Instrument Heathcare—17 Jul 19

Menarini Silicon Biosystems, the pioneer of liquid biopsy and rare cell technologies, announced that it will launch the new VRNxT(TM), a volume reduction instrument optimized to remove manual sample volume reduction steps in cellular biology

BREASTFEEDING CAMPAIGN SETS A NEW REGIONAL STANDARD FOR SUSTAINABLE Heathcare—10 Jul 19

The "6 months mother's milk is all you need" campaign has been awarded South East Asia PR Campaign of the year and Cause related public awareness campaign of the Year by Campaign Asia at the PR awards in Hong Kong last month. Initiated by Save The

Daewoong Pharmaceutical participated in the IMCAS Asia 2019 to introduce the excellence of Heathcare—09 Jul 19

Daewoong Pharmaceutical Co., Ltd, a world-leading botulinum toxin manufacturer in Korea, announced its participation in IMCAS Asia 2019 held in Bali, Indonesia July 5-7, 2019 to introduce the excellence of NABOTA(R) (Prabotulinumtoxin A). The 13th year

ISTH Announces Launch Of New Global Education Initiative In Gene Therapy For Heathcare—08 Jul 19

The International Society on Thrombosis and Haemostasis (ISTH) is pleased to announce the official launch of Gene Therapy in Hemophilia: An ISTH Education Initiative. This landmark launch, the first of its kind in hemophilia, will take place during the

Open nursing course to accelerate the safe practice of Peripheral Intravenous Cannula Heathcare—25 Jun 19

"Peripheral Intravenous Cannula Insertion is a very broad term and not likely to be understood by people outside the medical community. In simple terms, it means the provision of saline, medication or blood products through an intravenous device and

Sirtex Medical reaches milestone 100,000th patient dose delivery of SIR-Spheres(R) Y-90 resin Heathcare—25 Jun 19

- Physicians and employees recognized for their role in this milestone and impact made on patient lives Sirtex Medical, a leading manufacturer of targeted liver cancer therapies, today announced delivery of the 100,000th patient dose of SIR-Spheres(R)

Most Thai consumers want to improve their diets and are open to healthier product Heathcare—20 Jun 19

According to a new report by Food Industry Asia (FIA) and research firm IGD, almost all consumers in Thailand (99 per cent) are interested in improving their diets and a majority (82 per cent) are happy for products to be reformulated, provided that

Kemin Launches New Vision and Logo for the Future Heathcare—17 Jun 19

Global ingredient manufacturer sets sights on sustainably transforming 80 percent of the world by 2042 Today Kemin Industries, a global ingredient manufacturer, unveiled its new global vision and logo to align the company strategically for 2042 and

Oral semaglutide demonstrated cardiovascular safety in people with type 2 diabetes and established Heathcare—12 Jun 19

Novo Nordisk today announced that the PIONEER 6 trial achieved its primary endpoint by demonstrating non-inferiority of major adverse cardiovascular events (MACE) with oral semaglutide compared with placebo, both in addition to standard of care. The